This article has Open Peer Review reports available.
Physical activity and medicine use: evidence from a population-based study
© Bertoldi et al; licensee BioMed Central Ltd. 2006
Received: 23 March 2006
Accepted: 06 September 2006
Published: 06 September 2006
Few studies have investigated the association between physical activity practice and medicine use; data from these studies are inconsistent. The aim of this study was to evaluate the association between level of physical activity and medicine use in adults aged 20 years or more.
A population-based cross-sectional study was carried out in the first semester of 2002 in the urban area of Pelotas; a medium-sized Southern Brazilian city. Physical activity was assessed with the short version of the International Physical Activity Questionnaire. A physical activity score was created as the weekly time spent in moderate-intensity activities plus twice the weekly time spent in vigorous-intensity activities. Medicine use in the 15 days prior to the interview was also assessed. Adjusted analyses taking into account the sampling design was carried out using Poisson regression. Wald tests for heterogeneity and linear trend were used to calculate significance.
Out of the 3,182 individuals interviewed, 41% were not sufficiently active according to current physical activity guidelines. Only 34% of the subjects did not use medicines in the previous 15 days, and 18% used three or more drugs in the same period. Level of physical activity was inversely associated with the number of medicines used both in the crude and in the adjusted analyses.
There are well-documented benefits of physical activity for several chronic diseases in the literature. Data from the present study suggest that medicine use is also positively affected by physical activity behavior.
Lack of physical activity is now recognized as a major challenge for public health due to its association with several chronic diseases and consequent premature mortality [1–6]. The World Health Organization has included physical activity in the health agenda by creating the Global Strategy on Diet, Physical Activity and Health . However, assessment of physical activity has also been a challenge. In 2003, a group of researchers and institutions proposed the International Physical Activity Questionnaire (IPAQ), allowing investigators to carry out comparable studies on physical activity.
Medicine use is an indicator of general health status , and consequently, less active individuals may be more likely to use medicines. However, the literature on this association is scarce. Bardel et al, studying women aged 35–65 years, showed a higher frequency of medicine use in the less active group in the crude analysis. However, after adjusting for the confounding variables, the association was no longer significant. Eggen et al found no association between leisure-time physical activity and medicine use in Norway, in a study including adolescents and adults.
In a population-based study of Brazilian adults, the association between level of physical activity and medicine use was evaluated, carefully controlling for potential confounders, such as sex, age and economic status, and mediators, such as body mass index (BMI) and self-reported health status.
A cross-sectional population-based study was carried out in the first semester of 2002 in the urban area of Pelotas, a 320,000-inhabitant city in Southern Brazil. The sample was selected in two stages. The primary sample units were the census tracts; these were divided into four groups according to the mean schooling level of the household heads. Within each stratum, the census tracts were systematically selected with probability proportional to size. A total of 1,600 households were selected, 20 in each of the 80 tracts, through systematic sampling. All residents of the selected household aged 20 years or more were eligible for the investigation.
The sample size obtained (n = 3,182) allowed us to estimate the association between medicine use and physical activity level with a power of 90% using the following parameters: confidence level of 95%, prevalence of medicine use in the 15 days prior to the interview of 66%, prevalence of sedentary lifestyle of 27%, and prevalence ratio of 1.15 or above.
A pre-tested and standardized questionnaire was used to assess medicine use, with a recall period of 15 days. Interviewees were asked to show the prescriptions and packaging of all medicines used in the period. The name of the drug and the manufacturer were recorded. Physical activity was measured using the short version of the International Physical Activity Questionnaire (IPAQ), with a weekly recall. A physical activity score was created as the weekly time spent in moderate-intensity activities plus twice the weekly time spent in vigorous-intensity activities. The score was categorized into four groups – 0 minutes per week: inactive; 1–149 minutes per week: insufficiently active; 150–999 minutes per week: sufficiently active; ≥ 1000 minutes per week: highly active. The two least active groups do not reach current physical activity requirements of at least 150 minutes per week of moderate-intensity physical activities[3, 5].
Demographic and socioeconomic variables were also collected as potential confounders. These variables were age, sex, and economic status (according to the Brazil Criterion for Economic Classification proposed by ANEP, which considers both household assets and education of the household head). Families are classified from class A (wealthiest) to E (poorest). Body mass index – BMI (kg/m2) and self-reported health status (excellent, very good, good, average, or poor) were also assessed.
Interviewers were women with at least 11 years of formal education. They were trained for 40 hours and were not aware of the purposes and hypotheses of the investigation. Data were collected through face-to-face home interviews. For quality control purposes, 10% of the interviews were repeated by field supervisors.
Following descriptive analyses, the crude association between medicine use and physical activity was tested. In order to adequately adjust for confounders, Poisson regression was used. The effect of physical activity on medicine use was initially adjusted for the potential confounding effect of sex, age, and economic status. Thereafter, additional adjustment for mediators (BMI and self-reported health status) was also carried out. All tests were two-tailed, and the significance level used was 0.05. All analyses were performed accounting for the sample design by using the svy set of commands available in Stata version 8 (Statacorp, College Station, TX, 2003). The census tracts were defined as the primary sampling units, and weighting was not necessary, given the fact that the sample was self-weighted.
The project was approved by the Ethics Committee of the Federal University of Pelotas Medical School. Personal data were made anonymous, and informed consent was obtained from each subject prior to the interview.
In the 1,600 selected households, there were 3,372 individuals eligible for the study, of whom 3,182 (94.4%) answered the questionnaire. Analyses were carried out using 3,119 observations, as 63 subjects provided incomplete data on physical activity. The design effects for medicine use and physical activity were, respectively, 2.9 and 4.7, with intra-class coefficients of 0.046 and 0.094, respectively.
Description of the sample in terms of demographic and socioeconomic variables, physical activity and medicine use. Pelotas, Brazil, 2002.
Economic status *
A – B (wealthiest)
D – E
Body mass index (kg/m2)
Self-reported health status
Physical activity score (min/week)
Number of medicines used in the previous 15 days
Crude and adjusted prevalence ratios (PR) of medicine use in the 15 days prior to the interview according to physical activity score. Pelotas, Brazil, 2002.
Physical activity score
1.23 (1.12; 1.36)
1.13 (1.04; 1.24)
1.13 (1.03; 1.23)
1.18 (1.06; 1.31)
1.14 (1.04; 1.26)
1.14 (1.04; 1.26)
1.11 (1.01; 1.22)
1.07 (0.98; 1.17)
1.08 (0.99; 1.18)
≥ 1000 minutes/week
For comparison with a previously published study , we have repeated analysis exclusively for women aged 35–65 years. For this group, the increased risk for medicine use among sedentary women was 23%.
Data on medical diagnosis of diabetes and hypertension was collected among subjects aged 40 years or more. Based on this information, we repeated the analysis for individuals reporting either condition. Among diabetic patients (N = 219), 86.1% of the sedentary individuals were using medicines, compared to 64.5% among those in the more active group (P = 0.045). The same pattern was observed for hypertensive patients (N = 737). The prevalence of medicine utilization was 87.7% among sedentary patients, compared to 79.9% among the more active subjects (P = 0.09). These results did not change after adjustment for age.
To the best of our knowledge, this study is the first to report that physical activity practice is associated with a decreased risk of medicine use even after adjusting for confounders. Because both physical inactivity and medicine use are highly prevalent, the increased risk of medicine use among subjects who do not reach physical activity guidelines is relevant for public health, even with the low prevalence ratios detected. Rates of physical inactivity and medicine use in our sample were consistent with previous Brazilian reports [14–16].
A Swedish study including only middle-aged (35–65 years) women evaluated the association between occupational and leisure-time physical activity and medicine use. In the crude analysis, sedentary individuals showed 39% higher medicine use in comparison to very active women. In our study, the equivalent percentage was 23%. However, after adjusting for self-reported health status, BMI, age and educational level, the association between activity levels and medicine use failed to reach significance in the Swedish study. In our analysis (Table 2), the effect of physical activity on medicine use remained significant after adjustment for sex, age and economic status (model 1), and after inclusion of BMI and self-reported health status (model 2). A study in Norway found no relationship between leisure-time physical activity and medicine use. The fact that our study addressed all components of physical activity (occupational, commuting, leisure-time and household chores), and those mentioned above evaluated only fractions of it, might explain the different findings. If physical activity really affects medicine use, studies focusing on the whole behavior, such as ours, may be more likely to detect the association than those evaluating only fractions of it.
A recall period of 15 days was used to assess medicine utilization, and thus, some degree of recall bias is possible. Even so, 15 days (or two weeks) is the most frequent recall period used in the literature[11, 18–21]. Among the methodological strengths of the study, the low non-response rate (5.6%) and the similarity between the sample and the whole city census data (data not shown) should be noted. The measurement of the total amount (occupational, commuting, leisure-time and household chores) of physical activity, instead of fractions of it, should also be highlighted.
In previous publications [18, 22], we have shown that both medicine use and lack of physical activity were strongly associated with poor self-reported health status in this sample. However, these two variables are differently correlated with health. While physical activity has an important role in the prevention of unhealthy outcomes [1–6], medicine use is often a consequence of health status.
The initial hypothesis of our study was that physical activity should affect medicine utilization patterns through health status. However, our association was still significant after adjusting for self-reported health status. Therefore, the effect of physical activity practice on medicine utilization is partially independent of self-reported health status. We do not have a definitive explanation for this finding, but some hypotheses may be presented. First, although the association between physical activity and medicine use was significant, one should bear in mind that the cross-sectional design used may lead to reverse causality bias. Therefore, the hypothesis presented in this paper should be confirmed in prospective studies. Second, medicine use is not determined only by pharmacological factors. There are well-known variables which influence medicine use, related to social, anthropological, behavioral and cultural aspects . Thus, more active individuals may have different behavioral and cultural patterns, and be less likely to be influenced by these external factors which increase the likelihood of medicine use. Third, the missing impact of self-reported health status on the association between physical activity and medicine use, might be due to the pharmacological effect of medicine use on the perception of symptoms and health. Future studies may help understand this finding.
One should argue that the significant association described here is consequence of residual confounding. However, the fact that the adjusted analysis did not provide results substantially different from those obtained in the crude one, minimizes the likelihood of residual confounding. Another methodological aspect to be considered is that our conclusions are not based only on crude results; actually we have carried out two regression models and the association was confirmed in both. In the first model, we intended to remove the confounding effect of demographic and socioeconomic indicators. Thereafter, we have also adjusted for the mediating effect of BMI and self-reported health status, which are strongly associated both with the exposure and the outcome.
In summary, level of physical activity was inversely associated with the prevalence and number of medicines used in a population-based sample of adult Brazilians, although prospective studies are warranted in order to confirm temporality for this association. Therefore, it is possible that strategies aimed at increasing population levels of physical activity may help decrease the high rates of medicine use observed both in low-, middle- and high-income countries[10, 11, 18, 19, 24]. The fact that this association was confirmed among subjects with chronic diseases highlights its importance. It means that even after the disease is present, active individuals are less likely to use medicines.
This study was funded by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – CAPES. The funding agency had no role in the study design, data collection, analyses, interpretation of the findings or decision to submit the manuscript for publication.
- Lee IM, Paffenbarger RSJ, Hsieh CC: Physical activity and risk of prostatic cancer among college alumni. Am J Epidemiol. 1992, 135 (2): 169-179.PubMedGoogle Scholar
- Manson JE, Nathan DM, Krolewski AS, Stampfer MJ, Willett WC, Hennekens CH: A prospective study of exercise and incidence of diabetes among US male physicians. Jama. 1992, 268 (1): 63-67. 10.1001/jama.268.1.63.View ArticlePubMedGoogle Scholar
- Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, Buchner D, Ettinger W, Heath GW, King AC, et al: Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. Jama. 1995, 273 (5): 402-407. 10.1001/jama.273.5.402.View ArticlePubMedGoogle Scholar
- Thune I, Brenn T, Lund E, Gaard M: Physical activity and the risk of breast cancer. N Engl J Med. 1997, 336 (18): 1269-1275. 10.1056/NEJM199705013361801.View ArticlePubMedGoogle Scholar
- U.S. Department of Health and Human Services: Physical activity and health: a report of the Surgeon General. 1996, Atlanta, GA , U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health PromotionGoogle Scholar
- Wannamethee SG, Shaper AG, Walker M: Changes in physical activity, mortality, and incidence of coronary heart disease in older men. Lancet. 1998, 351 (9116): 1603-1608. 10.1016/S0140-6736(97)12355-8.View ArticlePubMedGoogle Scholar
- World Health Organization: Global Strategy on Diet, Physical Activity and Health. 2004, Geneva , World Health OrganizationGoogle Scholar
- Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P: International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003, 35 (8): 1381-1395. 10.1249/01.MSS.0000078924.61453.FB.View ArticlePubMedGoogle Scholar
- Neutel CI: Drug Utilization Patterns as Indicators. Pharmacoepidemiol Drug Saf. 1998, 7: 131-133. 10.1002/(SICI)1099-1557(199803/04)7:2<131::AID-PDS337>3.0.CO;2-I.View ArticlePubMedGoogle Scholar
- Bardel A, Wallander MA, Svardsudd K: Reported current use of prescription drugs and some of its determinants among 35 to 65-year-old women in mid-Sweden: A population-based study. J Clin Epidemiol. 2000, 53 (6): 637-643. 10.1016/S0895-4356(99)00228-0.View ArticlePubMedGoogle Scholar
- Eggen AE: Pattern of drug use in a general population - prevalence and predicting factors: the Tromso study. Int J Epidemiol. 1994, 23 (6): 1262-1270.View ArticlePubMedGoogle Scholar
- ANEP: Critério de classificação econômica Brasil. Associação nacional de empresas de pesquisa. 1996Google Scholar
- Barros AJ, Hirakata VN: Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003, 3 (1): 21-10.1186/1471-2288-3-21.View ArticlePubMedPubMed CentralGoogle Scholar
- Arrais PS, Brito LL, Barreto ML, Coelho HL: [Prevalence and determinants of medicines consumption in Fortaleza, Ceara, Brazil]. Cad Saude Publica. 2005, 21 (6): 1737-1746.View ArticlePubMedGoogle Scholar
- Matsudo SM, Matsudo VK, Araújo T, Andrade D, Oliveira L, Braggion G: Physical activity level of São Paulo state population: an analysis based on gender, socio-economic status, demographics and knowledge. Rev Bras Ciênc Mov. 2002, 10: 41-50.Google Scholar
- Monteiro CA, Conde WL, Matsudo SM, Matsudo VR, Bonsenor IM, Lotufo PA: A descriptive epidemiology of leisure-time physical activity in Brazil, 1996-1997. Rev Panam Salud Publica. 2003, 14 (4): 246-254.View ArticlePubMedGoogle Scholar
- Ungar W: Bias - It's everywhere! A commentary on the impact of bias and the assessment of agreement in the measurement of medication use in epidemiology research. Pharmacoepidemiology and drug safety. 1998, 7: 425-427. 10.1002/(SICI)1099-1557(199811/12)7:6<425::AID-PDS384>3.0.CO;2-V.View ArticlePubMedGoogle Scholar
- Bertoldi AD, Barros AJ, Hallal PC, Lima RC: [Drug utilization in adults: prevalence and individuals determinants]. Rev Saude Publica. 2004, 38 (2): 228-238.View ArticlePubMedGoogle Scholar
- Sans S, Paluzie G, Puig T, Balañá L, Balaguer-Vintró I: Prevalencia del consumo de medicamentos en la población adulta de Cataluña. Gac Sanit. 2002, 16 (2): 121-130.View ArticlePubMedGoogle Scholar
- Furu K, Straume B, Thelle DS: Legal drug use in a general population: association with gender, morbidity, health care utilization, and lifestyle characteristics. J Clin Epidemiol. 1997, 50 (3): 341-349. 10.1016/S0895-4356(96)00362-9.View ArticlePubMedGoogle Scholar
- Tobi H, Meijer WM, Tuinstra J, de Jong-van den Berg LT: Socio-economic differences in prescription and OTC drug use in Dutch adolescents. Pharm World Sci. 2003, 25 (5): 203-206. 10.1023/A:1025836704150.View ArticlePubMedGoogle Scholar
- Hallal PC, Victora CG, Wells JC, Lima RC: Physical inactivity: prevalence and associated variables in Brazilian adults. Med Sci Sports Exerc. 2003, 35 (11): 1894-1900. 10.1249/01.MSS.0000093615.33774.0E.View ArticlePubMedGoogle Scholar
- Lefevre F: [The supply and demand of instant health by means of drugs: proposal of a research field]. Rev Saude Publica. 1987, 21 (1): 64-67.View ArticlePubMedGoogle Scholar
- Abahussain E, Matowe LK, Nicholls PJ: Self-reported medication use among adolescents in Kuwait. Med Princ Pract. 2005, 14 (3): 161-164. 10.1159/000084633.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/6/224/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.